Active ingredientCrotamitonCat. No. P-C258-001CAS 483-63-6Family · Pharmaceutical analytical standards
Crotamiton
A topical medicine against scabies and against itching of various origins, such as insect bites: it was patented in the late 1940s in Switzerland and is still used today as a cream or lotion. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.
Did you know?For decades its anti-itch effect remained unclear: a 2017 study suggests that it blocks TRPV4, an ion channel in sensory nerve fibres.
Go to the active ingredient →Active ingredientCrotamitonCat. No. P-C258-001CAS 483-63-6
Pharmacopoeial impurityCrotamiton EP Impurity ACat. No. P-C258-002CAS 13936-71-5
Pharmacopoeial impurityCrotamiton EP Impurity BCat. No. P-C258-003CAS 1195353-67-3
Pharmacopoeial impurityCrotamiton EP Impurity DCat. No. P-C258-004CAS 13936-60-2
Impurity(E)-CrotamitonCat. No. P-C258-005CAS 124236-29-9
Impurity(Z)-CrotamitonCat. No. P-C258-006CAS 124236-30-2
ImpurityN-(2-Methylphenyl)but-2-enamideCat. No. P-C258-008CAS 96686-24-7No product matches your search.
EDQM standards 3
The official European Pharmacopoeia standards for this family.
Reference substanceCrotamiton CRSEDQM code C2970000Family CrotamitonImpurityCrotamiton impurity A CRSEDQM code C2970005Family CrotamitonNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.